Piccirillo Jay F, Merritt Michael G, Richards Michele L
Clinical Outcomes Research Office, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Otolaryngol Head Neck Surg. 2002 Jan;126(1):41-7. doi: 10.1067/mhn.2002.121022.
A valid measure of rhinosinusitis health status and quality of life is required for the complete assessment of treatment effectiveness. The purpose of this study was to analyze the psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20), a disease-specific, health-related quality-of-life measure for rhinosinusitis. The SNOT-20 is a modification of the 31-Item Rhinosinusitis Outcome Measure, and it contains 20 nose, sinus, and general items. To complete the instrument, patients indicate how much they are affected in each area and identify the 5 most important items. The SNOT-20 was completed by 102, 72, and 46 patients at the initial visit and at 6 months and 1 year after treatment commencement, respectively. Cronbach's alpha was 0.9; test-retest scores were highly correlated (r = 0.9). Patients who were more affected had greater SNOT-20 scores (P < 0.002), and patients who had improved had greater change scores (P < 0.04). Items identified as important had greater scores (P < 0.0001) and showed greater change scores (P < 0.0002). The SNOT-20 is a valid outcome measure for patients with rhinosinusitis; it describes the health burden and is sensitive to clinical change.
为全面评估治疗效果,需要一种有效的衡量鼻窦炎健康状况和生活质量的方法。本研究的目的是分析20项鼻鼻窦结局测试(SNOT-20)的心理测量和临床测量效度,这是一种针对鼻窦炎的、与健康相关的疾病特异性生活质量测量方法。SNOT-20是31项鼻窦炎结局测量的修订版,包含20项关于鼻子、鼻窦和一般情况的条目。为完成该量表,患者需指出每个领域受影响的程度,并确定5个最重要的条目。分别有102例、72例和46例患者在初诊时以及治疗开始后6个月和1年时完成了SNOT-20量表。克朗巴哈系数为0.9;重测分数高度相关(r = 0.9)。受影响更大的患者SNOT-20得分更高(P < 0.002),病情改善的患者变化得分更高(P < 0.04)。被确定为重要的条目得分更高(P < 0.0001)且变化得分更大(P < 0.0002)。SNOT-20是评估鼻窦炎患者的有效结局指标;它描述了健康负担,并且对临床变化敏感。